Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Int AIDS Soc. 2013 Feb 14;16:18023. doi: 10.7448/IAS.16.1.18023.

High-risk human papillomavirus infection in HIV-positive African women living in Europe.

Author information

  • 1Department of Infectious Diseases, Saint-Pierre University Hospital, Brussels Free University, Brussels, Belgium. deborah_konopnicki@stpierre-bru.be

Abstract

INTRODUCTION:

Cervical infection with high-risk human papillomavirus (HRHPV) induces cervical cancer and is present in 14% of women in Europe. We assessed the prevalence and incidence of cervical HRHPV in a cohort of HIV-positive women living in Belgium.

METHODS:

Prospective observational program of screening and follow up of HRHPV cervical infection performed by Hybrid Capture in 825 HIV-positive women between 2002 and 2011. Women without normal cervix at baseline were excluded.

RESULTS:

The final analysis included 652 women: median age 38 years, African origin (81%), median HIV follow-up (66 months), median CD4 count (426 cells/μL) and 79% on antiretroviral therapy (cART). At baseline, HRHPV prevalence was 43% and decreased significantly as both age and CD4 cell count increased: highest prevalence (100%) in women <30 years and <200 CD4/μL and lowest (19%) in women >40 years and >500 CD4/μL (p<0.0001, multivariate analysis). The relative risk (RR) to carry HRHPV at baseline decreases proportionally by 11% for each 5 years-age increase and by 11% for each 100 CD4 cells/μL rise (RR=0.89, 95% CI: 0.85-0.93; p<0.0001, Poisson regression for both). During follow-up, incidence rate of HRHPV was 13.4 per 100 women-years.

CONCLUSION:

We found a high HRHPV prevalence of 43% and an incidence rate of 13 per 100 women-years in this cohort of HIV-positive women living in Europe and on cART. Women under 40 years-age had the highest prevalence even with CD4 count >350 cells/μL. The magnitude of HRHPV epidemiology should prompt to evaluate the clinical efficacy of vaccines against HPV in HIV-infected women.

KEYWORDS:

CD4 cell count; Europe; HIV; HPV; cervix; incidence; prevalence; women

PMID:
23406965
[PubMed - indexed for MEDLINE]
PMCID:
PMC3574170
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Datapage Icon for PubMed Central
    Loading ...
    Write to the Help Desk